Consun Pharmaceutical Group's H1 Profit Jumps 25%

MT Newswires Live
2025/08/19

Consun Pharmaceutical Group (HKG:1681) booked 498.3 million yuan in attributable profit in the first half of 2025, rising 25% from 399.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.

Earnings per share were 0.58 yuan, compared with 0.49 yuan in the prior year.

Revenue rose 24% year on year to 1.57 billion yuan, figures showed.

The company announced a dividend of HK$0.33 per share, payable Sept. 19 to shareholders of record on Sept. 5.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10